- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Results
6
Companies which have announced upcoming dividend payments.
6 companies
Tong Ren Tang Technologies
Market Cap: HK$4.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.52
7D
1.4%
1Y
-33.1%
Jacobson Pharma
Market Cap: HK$2.2b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.07
7D
-0.9%
1Y
-35.9%
Pak Fah Yeow International
Market Cap: HK$723.0m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.35
7D
1.3%
1Y
-4.5%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.
2161
HK$1.92
7D
-3.0%
1Y
-35.1%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.2b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.13
7D
-1.1%
1Y
-24.3%
China Resources Pharmaceutical Group
Market Cap: HK$30.8b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.86
7D
0%
1Y
-11.5%